Low-Molecular-Weight Fe(III) Complexes for MRI Contrast Agents

Area of Science:

• Inorganic Chemistry
• Medical Imaging
• Materials Science

Background:

• Gadolinium(III)-based contrast agents are widely used in MRI.
• Concerns exist regarding the long-term toxicity of Gadolinium(III) agents.
• Iron(III) complexes offer potential advantages including high thermodynamic stability and low toxicity.

Purpose of the Study:

• To review recent advancements in low-molecular-weight Iron(III) complexes for MRI contrast agents.
• To explore Iron(III) complexes as alternatives to Gadolinium(III)-based agents.
• To highlight structural-relaxivity and stability relationships.

Main Methods:

• Literature review of recent progress in Iron(III) complexes for MRI.
• Summarization of mononuclear and multinuclear Iron(III) complex designs.
• Analysis of structure-property relationships (relaxivity, stability).

Main Results:

• Iron(III) complexes exhibit high thermodynamic stability and low long-term toxicity.
• These complexes demonstrate large relaxivity, particularly at higher magnetic fields.
• Mononuclear and multinuclear Iron(III) complexes are discussed with emphasis on their structural features.

Conclusions:

• Low-molecular-weight Iron(III) complexes are promising alternatives to Gadolinium(III) MRI contrast agents.
• Further research into structural design can optimize relaxivity and stability.
• Future perspectives focus on developing novel Iron(III) complexes for enhanced MRI applications.